Endotoxin-stimulated alveolar macrophage recruitment of neutrophils and modulation with exogenous surfactant.

OBJECTIVE To determine whether endotoxin-stimulated alveolar macrophages would attract neutrophils and whether exogenous surfactant treatment would modulate this chemoattraction. DESIGN Alveolar macrophages were harvested from bronchoalveolar lavage fluid and neutrophils from the blood of anesthetized guinea pigs. SUBJECTS Hartley guinea pigs. INTERVENTIONS Alveolar macrophages were suspended in RPMI 1640 and stimulated with 1 microg/mL of lipopolysaccharide (LPS), the supernatant removed and the alveolar macrophages were incubated in either RPMI or RPMI with surfactant at two different doses (292 microg/mL or 875 microg/mL) for 16 hrs. MEASUREMENTS AND MAIN RESULTS The supernatant was extracted from the alveolar macrophages and placed in a chemotaxis plate and the migration of neutrophils was measured. Chemotaxis of all cell types to be tested was measured by a change of absorbance on a microplate reader set at 492 nm. Results were compared with alveolar macrophages not stimulated with LPS, RPMI alone, and N formyl-methionyl-leucyl-phenylalanine (FMLP). The supernatant of the stimulated alveolar macrophages increased neutrophil chemotaxis as compared with unstimulated alveolar macrophages, and RPMI (p < .05). Surfactant treatment with 292 microg/mL significantly decreased LPS-stimulated alveolar macrophages induced neutrophil chemotaxis. Treatment with 875 microg/mL of surfactant did not alter neutrophil chemotaxis. CONCLUSIONS Alveolar macrophages stimulation with LPS increased the chemotaxis of neutrophils. Treatment with surfactant at a concentration of 875 microg/mL did not alter neutrophil migration; however, treatment with 292 microg/mL significantly decreased neutrophil chemotaxis suggesting that at low concentrations, surfactant inhibits chemokine release and may reduce pulmonary neutrophil sequestration in vivo.

[1]  C. Elbim,et al.  Interactions between neutrophils and cytokines in blood and alveolar spaces during ARDS. , 1996, American journal of respiratory and critical care medicine.

[2]  T. Casale,et al.  Neutrophil transepithelial migration is dependent upon epithelial characteristics. , 1996, American journal of respiratory cell and molecular biology.

[3]  G. Nieman,et al.  Surfactant replacement in the treatment of sepsis-induced adult respiratory distress syndrome in pigs. , 1996, Critical care medicine.

[4]  W. Chao,et al.  Inhibition of the human neutrophil respiratory burst by native and synthetic surfactant. , 1996, American journal of respiratory cell and molecular biology.

[5]  H. Wiedemann,et al.  Regulation of human alveolar macrophage inflammatory cytokines by tyloxapol: a component of the synthetic surfactant Exosurf. , 1995, Clinical immunology and immunopathology.

[6]  E. Moore,et al.  Reperfused gut elaborates PAF that chemoattracts and primes neutrophils. , 1995, The Journal of surgical research.

[7]  D. Steedman,et al.  Plasma elastase levels and the development of the adult respiratory distress syndrome. , 1995, American journal of respiratory and critical care medicine.

[8]  J. Milanowski,et al.  Chemotaxis of alveolar macrophages and neutrophils in response to microbial products derived from organic dust. , 1995, Journal of investigational allergology & clinical immunology.

[9]  C. Marsh,et al.  Immunosuppressive properties of surfactant and plasma on alveolar macrophages. , 1995, The Journal of laboratory and clinical medicine.

[10]  S. Hawgood,et al.  Functions of the surfactant proteins: A perspective , 1995, Pediatric pulmonology.

[11]  K. Steinberg,et al.  Improved survival of patients with acute respiratory distress syndrome (ARDS): 1983-1993. , 1995, JAMA.

[12]  J. Filep,et al.  Pulmonary surfactant lipids inhibit prostanoid production of guinea pig alveolar macrophages , 1994, Journal of leukocyte biology.

[13]  P. Nibbering,et al.  Pulmonary surfactant inhibits activation of human monocytes by recombinant interferon-gamma. , 1994, Immunology.

[14]  H. Wiedemann,et al.  Characterization of exosurf (surfactant)-mediated suppression of stimulated human alveolar macrophage cytokine responses. , 1994, American journal of respiratory cell and molecular biology.

[15]  T. Lacaze‐Masmonteil Pulmonary surfactant proteins. , 1993, Critical care medicine.

[16]  J. Brieland,et al.  Effect of acute inflammatory lung injury on the expression of monocyte chemoattractant protein-1 (MCP-1) in rat pulmonary alveolar macrophages. , 1992, American journal of respiratory cell and molecular biology.

[17]  M. A. Martin,et al.  Gram-negative sepsis and the adult respiratory distress syndrome. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  J. Repine,et al.  Neutrophils and adult respiratory distress syndrome: two interlocking perspectives in 1991. , 1991, The American review of respiratory disease.

[19]  E. A. Havell,et al.  Roles of tumor necrosis factor and macrophages in lipopolysaccharide-induced accumulation of neutrophils in cutaneous air pouches , 1990, Infection and immunity.

[20]  A. Harmsen,et al.  Role of alveolar macrophages in lipopolysaccharide-induced neutrophil accumulation , 1988, Infection and immunity.

[21]  W. Falk,et al.  A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration. , 1980, Journal of immunological methods.

[22]  T. Petty,et al.  Incidence and outcome of the respiratory distress syndrome in gram-negative sepsis. , 1979, Archives of internal medicine.

[23]  A. Jobe,et al.  Surfactant and the adult respiratory distress syndrome. , 1993, The American review of respiratory disease.

[24]  A. Fein,et al.  The risk factors, incidence, and prognosis of ARDS following septicemia. , 1983, Chest.